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Materials and Methods: Using the CBCT of the XRAD225Cx 
preclinical irradiator, 8 tissue equivalent cylinders of known 
composition and density (Gammex RMI, Middelton, WI) were 
imaged at 40kVp. The HU variation was plotted versus the 
product ρ times Zeff that yielded to a monotonically 
increasing curve. Based on this relationship and the tissues 
defined in the ICRU-44 report, interpolated tissues were 
created for ρZeff varying from 2 up to 27 with a 0.2 step. 
Tissue equivalent cylinders were irradiated with the 
XRAD225Cx (225kVp). Exit dose was measured with EBT3 films 
and compared to Monte Carlo (MC) calculations from our 
GATE model of the irradiator. On the CT images, tissue 
segmentation was performed either by manual assignation of 
the elemental composition provided by the manufacturer or 
by using the (HU, ρ, EC) method. Dosimetric impact of the 
(HU, ρ, EC) method was evaluated on mice CT comparing 
with manual segmentation for brain and femoral head 
irradiations. 
Results: Tissue equivalent exit dose measurements relative 
to solid water varied from 1.13 (AP6 adipose) down to 0.36 
(SB3 cortical bone). Max 2% deviation was found with MC dose 
calculation performed with manufacturer data and 4.3% with 
calculation performed with the (HU, ρ, EC) method. Mean 
deviations were respectively 1.1% and 1.8%. It must be 
noticed that the segmentation method was based on real 
human tissues defined in ICRU-44 whereas measurements 
were performed with substitutes with elemental composition 
slightly different from human tissue elemental composition. 
The (HU, ρ, EC) method applied on mice CT allowed the 
automatic definition of 125 tissues. Dosimetric impact of the 
(HU, ρ, EC) was significant for bony tissues (>25%). 
Conclusions: A robust tissue segmentation method was 
developed for dose calculation in preclinical radiation 
therapy based on the (HU, ρZeff) relationship. Our method 
was successfully tested by comparing exit dose 
measurements from materials of known composition with MC 
dose calculation. The method was applied on mice CT for 
brain and femoral head irradiation with significant dosimetric 
impact. 
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Purpose/Objective: To estimate the dosimetric impact of an 
endorectal balloon (ERB) on rectal wall (Rwall) dose 
distribution when using extreme dose constraints during the 
optimization of urethra-sparing prostatic SBRT plans. 
Materials and Methods: A total of ten cT1/3a N0 M0 prostate 
cancer patients, prospectively randomized in an European 
multicenter phase II trial of urethra-sparing SBRT, were 
simulated with and without a 100cc inflated ERB. Patients 
were treated with the ERB following a SBRT protocol of 36.25 
Gy in 5 fractions of 7.25 Gy to the PTV. The dose prescribed 
to the prostatic urethra (urethral planning risk volume, uPRV) 
was reduced to 32.5 Gy. The dose was delivered with two full 
rotational volumetric modulated arcs. Ten plans with ERB 
and ten without (Vmatref) were first optimized until dose 
prescription and normal-tissue constraints (ranging from 50% 
to 100% of prescribed dose) specified in the protocol were 
reached. Additional optimizations based on these 20 Vmatref 
plans were calculated by adding dose constraints to the 
posterior Rwall (D3%, D10% and D20%). Starting from Vmatref 
(with and without ERB), these dose constraints were lowered 
five times to obtain plans Vmat1 to Vmat5. A total of 120 
plans were analyzed. The homogeneity index (HI) for the PTV 
and uPRV were calculated to determine which optimization 
better spared Rwall without degrading the coverage of target 
volumes. Dose-volume histograms were analyzed for Rwall. 
The mean number of monitor units (MU) per optimization 
degree was recorded. 
Results: HI for PTV remained quasi-constant with and without 
ERB from Vmatref until Vmat3 (HI=0.091±0.013 with ERB vs. 
0.079±0.012 without) and then slightly degraded. HI for uPRV 
started at 0.083±0.026 for Vmatref with ERB vs. 0.094±0.025 
without, and constantly deteriorated with higher 
optimizations. For the dose range [8-16 Gy], Vmat3 spared 20 
to 27% more Rwall volume than Vmatref. The mean number of 
MU increased from Vmatref (2028±726) to Vmat4 (2582±877) 
and then dropped off for Vmat5 due to unreachable dose 
constraints.  
ERB vs. no ERB: All plans were similar in the high dose 
regions [24-36 Gy] with a dose ratio ERB/noERB of [1.00–
1.04]. In intermediate dose regions [12-24 Gy], dose ratio 
were below 1 for Vmatref [0.94-0.97], close to 1 for Vmat1,2 
and range [1.04-1.07] for Vmat3. In low dose regions [2.5-12 
Gy] all plans without ERB spared better the Rwall. In very low 
dose regions [0–2.5 Gy], plans with ERB were advantageous 
(dose ratio=0.80).  
Conclusions: Extreme optimization on Rwall is feasible for 
urethra-sparing SBRT without compromising PTV dose 
homogeneity. Dose constraints to the posterior Rwall are now 
added during the optimization process though without 
knowing the potential benefit on rectal toxicity reduction. 
The ERBs do not seem to decrease the high dose received by 
the Rwall but may help to the intrafraction reproducibility of 
volume and shape while on treatment.  
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Purpose/Objective: Superficial PTVs that extend close to or 
even involve the skin pose great difficulty for inverse 
planning algorithms. There is known uncertainty in build up 
and surface doses in treatment planning systems. To address 
this problem, a typical clinical protocol may consist of PTV-
cropping or adding bolus. The rationale for this is to ensure a 
more accurate dose calculation near the surface and 
adequate coverage of the PTV. In attempting to cover the 
build-up region the optimizer can result in a solution that 
leads to excess fluence delivered by tangential beam 
segments near the surface. Patient motion or setup errors 
that bring the target into the region of high fluence, may 
lead to excess dose near the patient's skin. The goal of this 
study is to optimize PTV-cropping or bolus thickness so as to 
(1) achieve optimal coverage of the PTV and (2) dampen the 
effect of excess tangential fluence associated with inversely-
planned helical tomotherapy treatments. 
Materials and Methods: We used a commissioned Monte 
Carlo (MC) model of the helical tomotherapy unit within the 
McGill Monte Carlo treatment planning (MMCTP) system to 
recalculate tomotherapy optimized plans in sarcoma 
patients. The model consists of an accurately benchmarked 
accelerator model including the binary MLC coupled to a 
EGSnrc/dosxyznrc calculation of the patient dose distribution 
in a CT representation. Five patients were MC recalculated in 
planned setup and with introduced setup error obtained from 
the daily MVCT imaging. 
Results: Fig. 1a shows the surface dose along the blue line 
for a: (1) tomotherapy plan, (2) MC recalculated plan, and (3) 
MC recalculated plan with introduced setup error. The 
tomotherapy skin dose is overestimated by 12% compared to 
the MC recalculated dose. The dose in proximity to the 
surface is increased by 10% with respect to the tomotherapy 
dose due to excess fluence near skin if setup errors on the 
order of 5 mm are considered. Fig. 1b shows the surface dose 
along the blue line with 1 cm bolus for the: (1) tomotherapy 
plan, (2) MC recalculated plan. The tomotherapy skin dose is 
overestimated by only 2% compared to MC. The use of bolus 
also eliminates skin overdose caused by setup errors and 
excess fluence (data not shown). 
 
 
Conclusions: We used accurate MC calculations to (1) design 
treatment planning strategies that improve plan robustness 
with respect to patient motion and setup errors; (2) evaluate 
the use of 'planning-bolus' (bolus used only for planning and 
not for treatment) and the actual delivered dose to the PTV 
in the patient treated with no bolus; (3) evaluate the 
necessary buildup or PTV cropping so that the dose to PTV is 
accurately calculated and the excess fluence near patient's 
surface is dampened. Our study shows that the amount of 
overlying material on the PTV must be at least 5 mm (by PTV 
cropping or bolus). A 'planning bolus' strategy improves plan 
robustness and eliminates excess fluence. PTVs cropped less 
than 4 mm from skin are sub optimally covered. 
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Purpose/Objective: To determine 3D reconstruction volume 
calculation in several modern external beam radiotherapy 
treatment planning systems, with focus on stereotactic 
radiosurgery. 
Materials and Methods: Five SRS patients were selected and 
contoured using BrainLab iPlan (volume is evaluated in 
contouring and planning tasks). GTV, CTV, PTV and organ at 
risks were contoured, exported using DICOM protocol, and 
imported in Varian Eclipse v.10, Philips Pinnacle v.9.8, Elekta 
Oncentra v.4.1 (manual and automatic customization) and 
Monaco v.3.3 (contouring and planning tasks) , Mobius3D 
v.1.3 and one non clinical use software (CERR v.3.3). 
Volumes (cm3) were calculated for reconstructed 3D contours 
in every TPS and then compared using mean, maximum and 
minimum volume between TPSs calculated volume and mean 
calculated volume.  
Results: Figure 1 summarize results for different TPS and 
clinical structures of different volumes. Higher spread of 
volume calculation is found in smaller volumes, mainly due to 
volume grid calculation, differences in voxel assignments and 
first and last contour management. This differences reach as 
much as 60% of mean volume for some TPSs for volumes 
